Detection of endonuclease activity

Patent metadata

Field	Value
Publication number	US-11530456-B2
Application number	US-201917041287-A
Country	US
Kind code	B2
Filing date	Apr 4, 2019
Priority date	Apr 4, 2018
Publication date	Dec 20, 2022
Grant date	Dec 20, 2022

Abstract

The present invention relates to methods for determining endonuclease activity in a sample. In particular, the present invention relates to a method for determining viable pathogenic bacteria in a sample based on patterns of endonuclease activity.

First claim

The invention claimed is:

1. A method for screening for Type II restriction endonuclease activity in a sample, the method comprising:
a) adding to a provided sample to be analyzed at least one first oligonucleotide, to obtain a first reaction composition, the at least one first oligonucleotide comprising a hairpin structure, wherein the stem of said hairpin structure comprises a first cleavage site for a first Type II restriction endonuclease;
b) adding a ligase to the first reaction composition obtained in a), to circularize at least two of the first oligonucleotides if a Type II restriction endonuclease present in the sample has cleaved the cleavage site in the first oligonucleotide, wherein the produced circularized molecules comprise part of stem-loop structures of the first oligonucleotide after Type II restriction endonuclease cleavage;
c performing an amplification reaction using the at least first circularized oligonucleotides as template; and
d detecting the amplified product from step c), thereby determining Type II restriction endonuclease activity in said sample.

2. The method according to claim 1 , wherein the sample is a biological sample.

3. The method according to claim 1 , wherein the sample is a biological sample, selected from the group consisting of tissue samples, saliva, blood, food samples, surface swipes, environmental samples, and plant samples.

4. The method according to claim 1 , wherein the sample is a biological sample selected from the group consisting of animal feed or food for human consumption, dairy products, milk, cream, fermented milk products, cheeses, butter, plants, vegetables, fruit, fish, fish products, egg, egg products, condiments and spices.

5. The method according to claim 1 , wherein the presence of Type II restriction endonuclease activity is indicative of viable microorganisms.

6. The method according to claim 1 , wherein the presence of Type II restriction endonuclease activity is indicative of viable bacteria.

7. The method according to claim 1 , wherein the presence of Type II restriction endonuclease activity is indicative of viable bacteria selected from the group consisting of listeria, Pseudomonas, Salmonella, Campylobacter, E.coli, Staphylococci, MRSA, Mycobacteria, Streptococcus, Neisseria, Klepsiella , and Vibrio.

8. The method according to claim 1 , wherein at least one further second oligonucleotide is added to the sample in step a), wherein said second oligonucleotide comprises a hairpin structure, wherein the stem of said hairpin structure comprises a cleavage site for said first Type II restriction endonuclease.

9. The method according to claim 1 , wherein the first restriction site for a first Type II restriction endonuclease is selected from the group consisting of restriction sites specific for EcoRI, PstI, XhoI, SacII, MboI, Lmo911II, BciVI, HaeIII, NlaIII, HphI, AvaII, PvuII, XmaIII, Fnu4HI, ScrFI, MtuHN878II or SmlI, and isoschizomers thereof.

10. The method according to claim 1 , further comprising screening said sample for Type II restriction endonuclease activity of at least one further Type II restriction endonuclease, using one or more further oligonucleotides comprising a hairpin structure, wherein the stem of said hairpin structure comprises a second cleavage site for a second Type II restriction endonuclease.

11. The method according to claim 1 , wherein said oligonucleotides have a length in the range 30-120 nucleotides.

12. The method according to claim 1 , wherein the first oligonucleotide is blocked at the 5′-end and/or the 3′-end to minimize undesired ligation reactions and/or exonuclease activity on the nucleotides.

13. The method according to claim 1 , wherein step a) and step b) are performed simultaneously, so that said ligase is added to the sample together with the at least first oligonucleotide.

14. The method according to claim 1 , wherein step a), step b) and step c) are performed simultaneously, so that said circularization, ligation and amplification is performed simultaneously.

15. The method according to claim 1 , wherein said amplification reaction d) is performed by a method selected from the group consisting of Rolling Circle Amplification (RCA), PCR, real-time-PCR, Southern blotting, quantitative PCR (qPCR), restriction fragment length dimorphism-PCR (RFLD-PCR), primer extension, DNA array technology, LAMP and isothermal amplification.

16. The method according to claim 1 , wherein said amplification reaction d) is performed by Rolling Circle Amplification (RCA).

17. The method according to claim 1 , wherein detection of Type II restriction endonuclease activity of:
XhoI, PstI and/or SacII or isoschizomers thereof is indicative of viable Pseudomanas in said sample;
MboI, Lmo911II and/or BciVI or isoschizomers thereof is indicative of viable Listeria in said sample;
HaeIII, NlaIII, and/or HphI or isoschizomers thereof is indicative of viable Campylobacter in said sample;
AvaII, PvuII and/or XmaIII or isoschizomers thereof is indicative of viable Salmonella in said sample;
Fnu4HI, ScrFI, and/or SmlI or isoschizomers thereof is indicative of viable Staphylococcus in said sample;
MtuHN878II is indicative of viable mycobacteria belonging to the Mycobacterium tuberculosis complex in said sample.

18. The method according to claim 1 , wherein the detection of endonuclease activity of:
Lmo911, BciVI, and/or BbvI or isoschizomers thereof; or
Lmo911, MboI, and/or BbvI or isoschizomers thereof;
is indicative of viable Listeria sp..

19. The method according to claim 1 , wherein the detection of endonuclease activity of:
Lmo911, BciVI, and/or MboI or isoschizomers thereof;
Lmo911, BciVI, and/or SalI or isoschizomers thereof;
Lmo911, BciVI, and/or TseI or isoschizomers thereof;
Lmo911, BciVI, and/or HaeIII or isoschizomers thereof;
Lmo911, BciVI, and/or BbvII or isoschizomers thereof;
Lmo911, MboI, and/or SalI or isoschizomers thereof;
Lmo911, MboI, and/or TseI or isoschizomers thereof;
Lmo911, MboI, and/or HaeIII or isoschizomers thereof; or
Lmo911, MboI, and/or BbvII or isoschizomers thereof;
is indicative of viable Listeria.

20. The method according to claim 1 , wherein at least one further second oligonucleotide is added to the sample in step a), wherein said second oligonucleotide comprises a hairpin structure, wherein the stem of said hairpin structure comprises a cleavage site for said first Type II restriction endonuclease;
wherein the first oligonucleotide and the second oligonucleotide are different in sequence;
wherein said first oligonucleotide and said second oligonucleotide have different loop sequences; and
wherein said first oligonucleotide and said second oligonucleotide have different stem sequences.

21. A method for screening for Type II restriction endonuclease activity in a sample, the method comprising:
a) adding to a provided sample to be analyzed at least one first oligonucleotide, to obtain a first reaction composition, the at least one first oligonucleotide comprising a hairpin structure, wherein the stem of said hairpin structure comprises a first cleavage site for a first Type II restriction endonuclease;
b) adding a ligase and a support oligonucleotide to the first reaction composition obtained in a), the support oligonucleotide facilitating hybridization by bridging the 5′-end and the 3′-end of said first oligonucleotide after endonuclease cleavage, to circularize the first oligonucleotides if a Type II restriction endonuclease pre

Assignees

• Univ Aarhus
• Univ Hong Kong Chinese

Inventors

• Hede Marianne Smedegaard
• Knudsen Birgitta Ruth
• Stougaard Magnus
• Ho Yi-Ping

Classifications

• C12Q2521/319

  Exonuclease · CPC title

• C12Q2531/125

  Rolling circle · CPC title

• C12Q1/68 Primary

  involving nucleic acids · CPC title

• C12Q2533/107

  Probe or oligonucleotide ligation · CPC title

• C12Q2525/301

  Hairpin oligonucleotides · CPC title